Health Care

Dr. Weber on CheckMate-238 for Melanoma

Dr. Weber on CheckMate-238 for Melanoma”

The trial included 906 patients with stages IIIB, IIIC, and IV resected melanoma who had a greater than 50% risk of relapse over five years.

"Our results demonstrate that nivolumab is more effective in treating patients with stage III and IV melanoma, cutting the risk of relapse by a third", said Principal investigator Dr Jeffrey S. Weber, Professor of medicine at NYU School of Medicine and deputy director of Perlmutter Cancer Center. "This shows the magnitude of benefit is impressive, and that this is the real deal". Ipilimumab is also the Food and Drug Administration (FDA)-approved standard of care adjuvant therapy for resected stage III melanoma in the US.

Another anti-PD-1 drug, pembrolizumab, is being tested as adjuvant therapy against placebo in patients with resected stage III melanoma in a phase III European Organisation for Research and Treatment of Cancer (EORTC) trial.

The majority (81%) of patients had stage III disease, 32% had ulcerated primary melanoma, 48% had macroscopic lymph node involvement and 42% harbored BRAF mutations.

After 12 months of continuous therapy, 71% of patients treated with nivolumab lived without recurrence of the disease, compared with 61% of those treated with ipilimumab. RFS in the intent-to-treat population served as the primary endpoint.

Median follow-up was 18.5 months. There were similar results across prespecified subgroups of patients.

OS served as a secondary endpoint. He also says that more studies are needed to examine why some patients relapse following treatment and others do not. The study observed treatment-related grade 3 or 4 adverse events in 14.4% of the patients in the nivolumab group compared to 45.9% in the ipilimumab group.

"To me, as a clinician, that is really the most practical issue when administering adjuvant therapy", Weber said during a press conference. Nivolumab combined with ipilimumab resulted in longer progression-free survival and a higher objective response rate than ipilimumab alone. "Compared with the high toxicity of ipilimumab, it is much more tolerable for the patients".

Although adjuvant nivolumab after resection may benefit more patients with high-risk disease, several interesting questions arise, Weber said.

"The safety of nivolumab is very promising", Dr Weber added. "The concern about BRAF/MEK is it clearly induces resistance".

John Haanen, PhD, head of the division of medical oncology at Netherlands Cancer Institute, called the CheckMate 238 findings exciting.

Serious treatment-related adverse events (AEs) were reported in 59% of the patients in the nivolumab-plus-ipilimumab group, 21% in the nivolumab group, and 28% in the ipilimumab group.

The benefit shown for nivolumab in metastatic disease and those pilot data provided the impetus for CheckMate 238, a randomised, double-blind, phase III trial comparing adjuvant treatment with nivolumab versus standard of care ipilimumab.

2 Weber J, Mandala M, Del Vecchio M, et al.

Disclosures: Bristol-Myers Squibb funded this study. Please see the abstract for a list of all researchers' relevant financial disclosures.



Like this

Latest


12 September 2017
Oklahoma moves up to No. 2 in AP poll behind Alabama
The Buckeyes did extend their streak of 41 polls ranked in the top 10, which dates back to the November 9, 2014. The Fighting Irish of Notre Dame dropped out of the AP college football poll after just one week in the polls.

12 September 2017
New CBA for W-League players
The FFA, the PFA, and players from each team had formed a "Working Party" in September 2016 to work toward an agreement. The two-year deal marks a considerable step-up from two seasons ago when there was no minimum salary in the league.

12 September 2017
Faulkner delighted with recall to Australian squad
I am excited to back in the group. "It is a good opportunity against a tough opposition in their own country", he said. He is happy to be back after his absence from the squad.

12 September 2017
Stockman Asset Management Takes Position in Duke Energy Corporation (DUK)
The utilities provider reported $1.01 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $1.01. Lombard Odier Asset Mgmt (Europe) Limited holds 9,471 shares or 0.27% of its portfolio. 4,295 are held by Tru Of Vermont.

12 September 2017
Piyush Goyal assures people Indian bullet train will be safe
If the bullet train will stop at all 12 stations, then it will cover the distance in two hours and fifty-eight minutes. The 500-km railway will link Mumbai and Ahmedabad in western India, with services planned to commence in 2023.

12 September 2017
RBC Bearings Inc (NASDAQ:ROLL) Stock Price While Sentiment Increases
Alliancebernstein Limited Partnership holds 0.03% of its portfolio in RBC Bearings Incorporated (NASDAQ:ROLL) for 406,367 shares. The firm owned 30,505 shares of the industrial products company's stock after buying an additional 281 shares during the period.

12 September 2017
Wynn Resorts, Limited (WYNN) Shares Sold by KBC Group NV
Envestnet Asset Management Incorporated holds 0.01% of its portfolio in Wynn Resorts, Limited (NASDAQ:WYNN) for 38,263 shares. Wynn Resorts, Limited (NASDAQ:WYNN) saw some unusual options trading on Thursday. 1,516,742 shares of the stock traded hands.

12 September 2017
Sick pilots force ailing Air Berlin to cancel flights
Flights from Düsseldorf to Curacao, Cancun, Havana, Varadero, Punta Cana and Puerto Plata will end on September 25, Air Berlin said.

12 September 2017
Mourinho plays down Champions League hopes
There's no winter break, like in other countries, although I have to admit that I love the Christmas period in English football. Following the press conference, the midfielder did join up with his colleagues for the open training session.

12 September 2017
Oppo A71 smartphone launched in India at Rs 12990
The Oppo F3 comes with a 5.5-inch full HD (1080x1920 pixel resolution) In-Cell display and 2.0mm thin screen bezels. On the camera front, the A71 is mounted with 13MP rear camera with f/2.2 aperture, PDAF and LED Flash.



Recommended